Research suggests that taking just 3,000 steps a day can significantly slow the progression of Alzheimer’s disease. Updated guidelines from the World Health Organization (WHO) in July 2026 indicate that stepping up to 5,000 to 7,500 steps daily yields even better results, making regular walking an effective preventive measure against cognitive decline.
Continuity is Key
Experts recommend engaging in 150 to 300 minutes of moderate activity each week. The duration of uninterrupted activity is particularly crucial. A study conducted by the City University of Hong Kong, involving over 66,000 participants from the UK Biobank, revealed that those who manage continuous activity sessions of approximately 13 minutes greatly reduce their risk of dementia.
Participants with the highest continuity had an 82% lower risk of developing dementia. Additionally, MRI scans showed larger hippocampal volumes, which is the brain region central to memory.
Strength Training Protects Genes
Cardiovascular fitness is essential, but muscle strength also plays a vital role. The German Cancer Research Center (DKFZ) recommends 40 to 60 minutes of strength training each week. This not only helps prevent age-related muscle loss but also, according to research published in “Nature Ageing,” three hours of strength training weekly can prevent up to 56% of age-related genetic changes.
To support muscle development, experts advise a protein intake of 1.0 to 1.2 grams per kilogram of body weight daily. For those engaged in intensive training, this requirement can rise to 1.8 grams.
Nutrition as a Gamechanger
Prevention works best in tandem with a healthy diet. A study in “JAMA Network Open” that involved 1,800 participants found that an anti-inflammatory diet can reduce the risk of dementia by 29%. Notably, the MIND diet—a mix of Mediterranean and Nordic eating styles—has the potential to lower the risk by up to 40%.
AI Detects Alzheimer’s Years in Advance
Technology plays a crucial role in early detection. The AI model NITROGEN predicts Alzheimer’s disease with over 92% accuracy, potentially up to seven years before symptoms appear. Existing medications are also showing encouraging results; SGLT2 inhibitors can reduce risk by 43%, while GLP-1 agonists lower it by 33%.
Pharmaceutical company Roche is currently testing a new drug named “PrevenTRON,” with a Phase III study involving 1,600 asymptomatic at-risk individuals underway.
Bavaria Invests in Care
Research insights need appropriate structures for practical application. Since 2020, Bavaria has invested around €410 million in care facilities. New senior centers in Thierhaupten and Augsburg, which opened in July 2026, are specifically tailored for dementia-sensitive and intercultural care.
Movement in the Community
Community projects bring prevention to life. “Fit in Frankfurt” focuses on walking groups, while the Vogelsberg district plans to launch the project “We Move Ahead” in September 2026, with hundreds already registered.
AOK NordWest is also contributing by developing scientifically grounded training programs aimed at fall prevention for those in need of care.
Digital and Active
Events like the summer festival “Active in Old Age” in Leverkusen combine movement with digital engagement. In addition to sports offerings, training sessions for using digital media are also provided. The idea is to foster social integration, which promotes cognitive vitality and keeps older adults fit for longer.
Disclaimer: This article does not constitute investment advice, nor does it recommend any buying or selling activity. Information about stock prices, companies, and markets is provided without guarantee; changes may occur at any time. Investing in stocks can lead to significant losses. Our contributions are partially or fully automated with the support of AI and are reviewed.
